| Form | Liquid |
|---|
| Host Species | Human |
|---|
| Clonality | Monoclonal |
|---|
| Isotype | IgG1, kappa |
|---|
| Purity | >95% purity as determined by SDS-PAGE. |
|---|
| Purification | Protein A/G purified from cell culture supernatant. |
|---|
| Concentration | 2.53mg/ml |
|---|
| Endotoxin Level | Please contact the lab for this information. |
|---|
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
|---|
| Species Reactivity | Zaire ebolavirus |
|---|
| Target | Envelope glycoprotein, GP1, 2, GP, Shed GP, GP1, 2-delta, GP1, GP2, GP |
|---|
| Storage Buffer | 0.01M PBS, pH 7.4. |
|---|
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
|---|
| Expression System | Mammalian Cells |
|---|
| Accession Number | Q05320 |
|---|
| Background | Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and agent Administration (FDA)-approved monoclonal antibody to target Zaire ebolavirus (EBOVs) infection.
|
|---|
| Alternative Names | REGN-3470-3471-3479, REGN-3470/REGN-3471/REGN-3479, REGN-EB3, REGNEB3, Inmazeb(atoltivimab, maftivimab, odesivimab-ebgn), 2135632-30-1 |
|---|
| Note | For research use only. Not suitable for clinical or therapeutic use. |
|---|